Cures & Capital

• Aaron Schacht on the pharmaceutical industry's grand challenge and managing R&D at scale

  In this episode, we talk to Aaron Schact, the CEO and Board Director at BiomEdit and former R&D leader at Eli Lilly and Elanco. We discuss how to improve biopharma's R&D productivity and the industry's "grand challenge", why R&D productivity is the mental model for managing R&D at scale, practical advice on how to approach and work with R&D productivity, and much more!If you want to connect with us - we would love to hear from you:Linkedin: https://www.linkedin.com/company/cures-capital-podcastIf you prefer to watch the episode as a video, you can also get the podcast from YouTube, just search for "Cures & Capital".If you want to connect with Aaron or read about BiomEdit:Linkedin: https://www.linkedin.com/in/aaronlschacht/BiomEdit: https://www.biomedit.comResearch paper: "How to improve R&D productivity: the pharmaceutical industry's grand challenge"Link: https://www.nature.com/articles/nrd3078Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.

  --------  

  53:52
• Matthias Krings on crafting winning biopharma strategies and smart decisions

  In this episode, our guest is Dr. Matthias Krings - a senior partner at Catenion, a biopharma strategy consulting firm.Matthias is a seasoned veteran in biopharma strategy.In this conversation, he shares his playbook for achieving success as a biopharma company.As critical pillars for biopharma success, we dive into strategy processes, decision-making, and effective R&D risk management.If you want to connect with us - we would love to hear from you:LinkedIn: https://www.linkedin.com/company/cures-capital-podcastYou can also watch the full episode on our YouTube channel.Get in touch with Catenion: www.catenion.comYou can get in touch with Matthias through the Catenion website or via LinkedIn. Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.

  --------  

  49:42
• Stephan Christgau on applying the VC mindset in biotech & pharma

  How do venture capitalists think? And how do they define and create value in the life science industry?In this episode, we talk to Stephan Christgau, founding partner of Eir Ventures, about the VC mindset, investment decision-making and portfolio strategy. We dive into how VCs assess risk, balance high-stakes opportunities, and what could pharma and biotech companies learn from the VC way of doing things.If you want to connect with us - we would love to hear from you:Linkedin: https://www.linkedin.com/company/cures-capital-podcastIf you prefer to get the episodes as a video, you can watch our talking heads on YouTube.If you want to connect with Stephan or read about Eir Ventures:Linkedin: https://www.linkedin.com/in/stephan-christgau-6464392/Eir Ventures: https://www.linkedin.com/company/eir-ventures/Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.

  --------  

  1:03:16
• Murray Aitken's guide to biotech & pharma leaders: Navigating great uncertainty and complexity

  In this episode, we sit down with Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, to discuss the trends shaping the life sciences industry in 2025 and beyond.How do we navigate the life sciences industry in times of great uncertainty?Murray has observed the life sciences industry for decades and lays out his balanced perspective of the state of the industry and the underlying uncertainties, challenges and opportunities. This episode is a must-watch for anyone who wants to know what is going on in the industry. If you want to connect with us - we'd love to hear from you:Linkedin: https://www.linkedin.com/company/cures-capital-podcastIf you prefer to watch the episode, check our YouTube channel:https://www.youtube.com/@CuresCapitalIf you want to connect with Murray or follow up on the latest insights from IQVIA:Linkedin: https://www.linkedin.com/in/murray-aitken-iqviainstitute/IQVIA: https://www.iqvia.com/Report: 2025 Indicators of Progress for Advancing Health GloballyLink: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/2025-indicators-of-progress-for-advancing-health-globallyReport: Global Trends in R&D 2024: Activity, productivity, and enablersLink: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2024-activity-productivity-and-enablersDisclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.

  --------  

  1:00:30
• Mike Rea on why pharma struggles with innovation - and how to fix it

  In this episode, Mike Rea - CEO, IDEA Pharma - takes us on a journey through innovation and value creation in pharma. It is not all roses!He shares his candid views on what the pharmaceutical industry needs to do better to be less confused about innovation.Mike Rea also explains the importance of getting the definition of innovation right in drug development. Early commercial involvement in drug R&D is another key pillar in his drug innovation philosophy.We also get to discuss organizational design and team size conducive to unlocking pharma's innovation potential.You can easily get in touch with Mike Rea through LinkedIn, X, etc.If you want to connect with us - and join the discussions with other listeners:Linkedin: https://www.linkedin.com/company/cures-capital-podcastYouTube - watch the interview:https://www.youtube.com/@CuresCapitalDisclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.

  --------  

  1:08:13

Flere Forretning podcasts

Trendige Forretning podcasts

Om Cures & Capital